Wyeth – Latest Company News
Friday, September 11th, 2009Ligand receives $250,000 from Wyeth
17 Oct 2007
The payment arises from an agreement between the two companies and reflects progress in the development of bazedoxifene, a selective estrogen receptor modulator. Bazedoxifene is a synthetic drug that was designed to reduce the risk of osteoporotic fractures while protecting breast and uterine tissues. Wyeth received an approvable letter [...]
2 comments fortune | Wyeth |











